- Additional Authors
- Center for Biologics Evaluation and Research (U.S.)
- Description
- i, 14 p. : digital, PDF file.
- Alternative Title
- Use of serological tests to reduce the risk of transmission of trypanosoma cruzi infection in whole blood and blood components for transfusion and human cells, tissues, and cellular and tissue-based products (HCT/Ps)
- Subject
- Note
- Title from PDF title page (viewed on June 4, 2009).
- "Draft guidance".
- "March 2009".
- Includes bibliographical references (p. 12-14).
- System Details (note)
- Mode of access: Internet at the FDA web site. Address as of 6/4/09: http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Tissue/ucm126098.pdf ; current access is available via PURL.
- Call Number
- GPO Internet HE 20.4802:SE 6
- OCLC
- 370471736
- Title
Guidance for industry [electronic resource] : use of serological tests to reduce the risk of transmission of trypanosoma cruzi infection in whole blood and blood components for transfusion and human cells, tissues, and cellular and tissue-based products (HCT/Ps).
- Imprint
Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2009]
- System Details
Mode of access: Internet at the FDA web site. Address as of 6/4/09: http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Tissue/ucm126098.pdf ; current access is available via PURL.
- Connect to:
- Added Author
Center for Biologics Evaluation and Research (U.S.)
- Gpo Item No.
0499-T-02 (online)
- Sudoc No.
HE 20.4802:SE 6
- Research Call Number
GPO Internet HE 20.4802:SE 6